earnings
IM
NASDAQ · IMRX
Immuneering Corporation
Healthcare · Biotechnology
$3.68
Up+$0.10 (+2.73%)
Updated Nov 4, 2026, 7:41 PM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 224.71M
- P/E ratio
- -3.59
- Dividend yield
- 0.00%
- 52-week range
- $3.38 – $6.89
- Volume
- 879.44K
- Avg. volume
- 1.88M
Price performance · IMRX
IMRX price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
IMRX closed at $3.68 after 21 trading sessions, down 3.92% for the selected period.
- Last close
- $3.68
- Period change
- -3.92%
- Period low
- $3.42
- Period high
- $4.02
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $3.52 | $3.76 | $3.52 | $3.68 | 879.44K |
| Nov 2, 2026 | $3.76 | $3.94 | $3.445 | $3.49 | 799.89K |
| Oct 30, 2026 | $4.01 | $4.07 | $3.72 | $3.745 | 1.14M |
| Oct 29, 2026 | $3.99 | $4.10 | $3.87 | $4.02 | 777.03K |
| Oct 28, 2026 | $3.80 | $4.155 | $3.79 | $3.99 | 1.44M |
| Oct 27, 2026 | $3.72 | $3.888 | $3.70 | $3.83 | 700.08K |
| Oct 26, 2026 | $3.73 | $3.78 | $3.65 | $3.71 | 579.8K |
| Oct 23, 2026 | $3.78 | $3.78 | $3.585 | $3.73 | 726.54K |
| Oct 22, 2026 | $3.72 | $3.835 | $3.70 | $3.81 | 527.13K |
| Oct 21, 2026 | $3.73 | $3.80 | $3.6801 | $3.74 | 481.88K |
| Oct 20, 2026 | $3.70 | $3.841 | $3.67 | $3.73 | 926.84K |
| Oct 19, 2026 | $3.61 | $3.67 | $3.5601 | $3.66 | 427.11K |
| Oct 16, 2026 | $3.65 | $3.68 | $3.575 | $3.59 | 747.89K |
| Oct 15, 2026 | $3.42 | $3.71 | $3.38 | $3.64 | 934.29K |
| Oct 14, 2026 | $3.51 | $3.598 | $3.41 | $3.42 | 805.72K |
| Oct 13, 2026 | $3.86 | $3.86 | $3.545 | $3.56 | 741.06K |
| Oct 12, 2026 | $3.94 | $3.945 | $3.8139 | $3.86 | 529.79K |
| Oct 9, 2026 | $3.75 | $3.955 | $3.68 | $3.94 | 709.72K |
| Oct 8, 2026 | $3.83 | $3.83 | $3.60 | $3.74 | 1.92M |
| Oct 7, 2026 | $3.78 | $3.915 | $3.74 | $3.86 | 747.68K |
| Oct 6, 2026 | $4.06 | $4.09 | $3.81 | $3.83 | 898.44K |
Latest IMRX news
The latest Smart Investors Daily articles mentioning IMRX.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…